Blood Screening Market Size

Blood Screening Market Size

Blood Screening Market size was valued at around USD 3.2 billion in 2023 and is anticipated to register a CAGR of 7.3% between 2024 and 2032. This robust market growth can be attributed to various factors, including the continual technological advancements, rise in blood donation activities, increasing prevalence of infectious diseases, surging demand for blood transfusion diagnostics procedures, and growing healthcare infrastructure.

To get key market trends

  Download Free Sample

Moreover, the continuous incidences of infectious diseases such as HIV, hepatitis, and syphilis needs strict blood screening methodology. As these diseases can spread through blood transfusions, proper screening is critical in preventing their propagation. For instance, according to World Health Organization (WHO), by the end of 2022, around 39.0 million individuals were infected with HIV. Out of which 1.5 million are HIV-positive children (0-14 years old).

Furthermore, an increase in medical operations, surgeries, and treatments, such as organ transplants and cancer therapies, contributes to a greater need for safe and appropriate blood-related products. Thus, there is a greater demand for complete blood testing at regular intervals for patients undergoing different treatments.

Blood screening refers to the process of testing a blood sample to assess various parameters and detect the presence of specific substances or conditions within the blood. The main objectives of blood screening is to ensure the safety of blood transfusions, identify potential health issues, and monitor specific markers that may indicate diseases or infections.